These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28530894)

  • 21. Zoster vaccine protects against shingles.
    BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Bader MS
    Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
    Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
    Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination to prevent herpes zoster in older adults.
    Gnann JW
    J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
    Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
    Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which patients should receive the herpes zoster vaccine?
    Short MD; Fergus C
    JAAPA; 2019 Sep; 32(9):18-20. PubMed ID: 31460969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
    Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ
    Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing herpes zoster in immunocompromised patients: Current concepts.
    Calabrese C; Kirchner E; Fernandez J; Calabrese LH
    Cleve Clin J Med; 2024 Jul; 91(7):437-445. PubMed ID: 38950984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shingles vaccine.
    Willison CB; Morrison LK; Mendoza N; Tyring SK
    Expert Opin Biol Ther; 2010 Apr; 10(4):631-8. PubMed ID: 20113211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
    Cunningham AL; Heineman T
    Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes zoster vaccine. Poorly effective in those who need it most.
    Prescrire Int; 2012 Dec; 21(133):291. PubMed ID: 23373094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.
    Drolet M; Zhou Z; Sauvageau C; DeWals P; Gilca V; Amini R; Bénard É; Brisson M
    CMAJ; 2019 Aug; 191(34):E932-E939. PubMed ID: 31451524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes zoster prevention: A difficult problem to solve.
    Esposito S; Principi N
    Vaccine; 2018 Aug; 36(36):5442-5448. PubMed ID: 28784283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.
    Kawai K; Preaud E; Baron-Papillon F; Largeron N; Acosta CJ
    Vaccine; 2014 Mar; 32(15):1645-53. PubMed ID: 24534737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination for preventing postherpetic neuralgia.
    Chen N; Li Q; Zhang Y; Zhou M; Zhou D; He L
    Cochrane Database Syst Rev; 2011 Mar; (3):CD007795. PubMed ID: 21412911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term persistence of zoster vaccine efficacy.
    Morrison VA; Johnson GR; Schmader KE; Levin MJ; Zhang JH; Looney DJ; Betts R; Gelb L; Guatelli JC; Harbecke R; Pachucki C; Keay S; Menzies B; Griffin MR; Kauffman CA; Marques A; Toney J; Boardman K; Su SC; Li X; Chan IS; Parrino J; Annunziato P; Oxman MN;
    Clin Infect Dis; 2015 Mar; 60(6):900-9. PubMed ID: 25416754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes zoster and vaccination: a clinical review.
    Adams EN; Parnapy S; Bautista P
    Am J Health Syst Pharm; 2010 May; 67(9):724-7. PubMed ID: 20410546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
    Kovac M; Lal H; Cunningham AL; Levin MJ; Johnson RW; Campora L; Volpi A; Heineman TC;
    Vaccine; 2018 Mar; 36(12):1537-1541. PubMed ID: 29463421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.